StonvexLoading…
StonvexStonvexStonvexCore line items from BVS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-28 | Annual 2025 2025-12-31 | Q3 2025 2025-09-27 | Q2 2025 2025-06-28 |
|---|---|---|---|---|
Revenue | $132.09M | $568.09M | $410.19M | $271.54M |
Operating Income | $8.42M | $53.98M | $34.49M | $23.24M |
Net Income | $3.11M | $22.73M | $7.98M | $4.82M |
EPS (Diluted) | $0.04 | $0.33 | $0.12 | $0.07 |
Total Assets | $650.54M | $683.56M | $701.59M | $706.79M |
Total Liabilities | $416.27M | $455.11M | $494.34M | $505.49M |
Cash & Equivalents | $35.85M | $51.24M | $42.16M | $32.91M |
Free Cash Flow OCF − CapEx | $8.36M | $72.11M | $34.72M | $5.10M |
Shares Outstanding | 70.01M | 68.91M | 68.79M | 68.77M |